BI-RADS Categories and Management
The Breast Imaging Reporting and Data System (BI-RADS) is a standardized classification system with 7 categories (0-6) that directly link imaging findings to specific management recommendations, mandated by the Mammography Quality Standards Act for uniform reporting of breast imaging results. 1, 2
BI-RADS Category Definitions and Management
Category 0: Incomplete Assessment
- Definition: Needs additional imaging evaluation and/or prior mammograms for comparison
- Management: Obtain additional imaging (spot compression, magnification views, special mammographic views, or ultrasound) before final assessment 1
- Context: Almost always used in screening situations when a finding requires further workup
Category 1: Negative
- Definition: Completely normal mammogram with symmetric breasts, no masses, architectural distortion, or suspicious calcifications
- Malignancy risk: 0%
- Management: Resume routine annual screening mammography 1, 2
Category 2: Benign Findings
- Definition: Negative mammogram with identifiable benign findings (calcifying fibroadenoma, oil cyst, lipoma, intramammary lymph nodes, vascular calcification, implants, or post-surgical architectural distortion)
- Malignancy risk: 0%
- Management: Resume routine annual screening mammography 1, 2
Category 3: Probably Benign
- Definition: Finding with high probability of being benign
- Malignancy risk: <2%
- Management: Diagnostic mammograms at 6 months, then every 6-12 months for 1-2 years 2
- If stable or resolved: return to routine screening
- If increased size or changed characteristics: proceed to biopsy
- Exception: Consider initial biopsy if patient has uncertain follow-up compliance, strong desire for biopsy, or strong family history of breast cancer 2
Category 4: Suspicious Abnormality
- Definition: Lesions with variable probability of malignancy, not obviously malignant but requiring tissue diagnosis
- Malignancy risk: Greater than Category 3 but less than Category 5 (variable range)
- Management: Tissue diagnosis required using core needle biopsy (preferred) or needle localization excisional biopsy with specimen radiograph 2
- Critical requirement: Pathology-imaging concordance must be verified
- If discordant: repeat imaging and/or additional tissue sampling; surgical excision if discordance persists
- If benign and concordant: follow-up mammography every 6-12 months for 1-2 years before returning to routine screening 2
Category 5: Highly Suggestive of Malignancy
- Definition: Lesions with high probability of cancer (≥95%), including spiculated masses or malignant-appearing pleomorphic calcifications
- Malignancy risk: ≥95%
- Management: Tissue diagnosis required using core needle biopsy (preferred) or needle localization excisional biopsy 1, 2
- Critical requirement: Pathology-imaging concordance essential; benign pathology with Category 5 imaging is clearly discordant and unacceptable—requires surgical excision 2
Category 6: Known Biopsy-Proven Malignancy
- Definition: Breast lesions confirmed malignant through biopsy but before definitive therapy
- Management: Manage according to breast cancer treatment guidelines 1, 2
- Note: This category was added in the 4th edition to track known cancers during pre-treatment imaging 1
Important Clinical Considerations
When multiple imaging modalities are used (e.g., mammography plus ultrasound), the final BI-RADS category represents cumulative findings from both studies and reflects the most worrisome finding present 1. The category can change (increase, decrease, or remain the same) based on subsequent imaging 1.
For Categories 4 and 5, concordance between pathology and imaging is non-negotiable. Any discordance mandates repeat imaging, additional tissue sampling, or surgical excision to prevent missed cancers 2.
The system applies uniformly to screening (asymptomatic) and diagnostic (symptomatic) populations, though this can create confusion in recommendations 2.